Optimizing the Therapeutic Dose of Apatinib Mesylate Tablets in Patients With Lung Cancer by Dose Titration：A Real World Exploratory Study

NCT03594682 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

31

Enrollment

OTHER

Sponsor class

Conditions

NSCLC Stage IV
NSCLC Stage IIIB

Interventions

OTHER: Intervention/treatment

Sponsor

Beijing Chest Hospital